Aigenpulse is our new state of-the-art data intelligence platform which is designed to help you to expedite the drug discovery and development process. By harnessing the latest artificial intelligence and machine learning tools, it delivers advanced data analytics to underpin scientific decision making.
Built specifically for the R&D enterprise, the Aigenpulse Platform unifies silos promoting data re-use, provides automated processing, analysis and report templating, offers in-built statistics, visualisation and machine learning tools, enabling high-quality outputs to be generated at multiple stages of the R&D life cycle.
There is no other enterprise data analytics SaaS solution suited to the life sciences quite like the Aigenpulse Platform. Our clearly differentiated approach is focussed around three key customer value drivers: reuse, quality and efficiency.
The Aigenpulse Platform lowers the barrier to entry to digital transformation and is an enabling technology for users to leverage true machine learning on their organisation’s data, augmented with public and external assets.
Aigenpulse blends biotechnology and data analytics to drive your research further
Aigenpulse is the intelligence platform for Life Sciences. It is configurable and modular, and continuously adapts to the unique research requirements and structures of your organisation.
The Aigenpulse Platform enables the integration of multi-omics R&D and clinical data to support high quality decision making in a secure, audited and scalable environment.
The Aigenpulse Platform provides a low barrier to entry for advanced analytics and machine learning, facilitating high powered analysis to underpin more scientific research.
Expedite your drug discovery process
Delve deeper into your data
Experiment Suites, which solve specific challenges and are focused on one type of scientific data, are mapped to organisation-wide sets of samples, vocabularies and ontologies, enabling a centralised, accessible, auditable repository of data (raw, processed and analysed), analysis, ML models and reports.
The CytoML Suite allows for streamlining and automation of cytometry analysis at scale. The Proteomics Suite lets you seamlessly structure and integrate all proteomics data from in-house and external sources.
We help you to overcome data siloes and our integration approach means you can interact with and exchange data across systems, sources and software. The Aigenpulse Platform provides a fully RESTful API service for you to connect programmatically and retrieve structured, labelled data and invoke large scale processing and analysis jobs.
The API also connects to other systems, sources and software that are typically used in the life sciences, such as LIMS and ELNs.
Compliance is in our DNA and we have developed an automated system to collect, template and store the evidence required for any configuration of the Aigenpulse Platform. We provide automatic QA/QC on datasets, an end-to-end breadcrumb trail to ensure reproducibility of analytics and GAMP5/GxP alignment for use in regulated development, clinic and manufacturing.
We have built the Aigenpulse Platform from the ground up with safety and security of data as a principal priority. We are certified to ISO 9001 and ISO 27001:2013, so you can rest assured that our platform will enable you to effectively manage risks that affect data confidentiality, integrity and availability.